2021
DOI: 10.1016/j.jhep.2020.07.028
|View full text |Cite
|
Sign up to set email alerts
|

Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis

Abstract: Hepatocytes Blood 11 C-CSar 11 C-CSar in bile ducts OCA-induced increase over placebo 0% 10% 70% PET of hepatic 11 C-CSar kinetics 11 C-CSar 11 C-CSar in biliary canaliculi Hepatocytes Highlights A randomised, placebo-controlled, crossover PET study of 8 patients with PBC.OCA enhances secretion of conjugated bile acids from hepatocytes into biliary canaliculi.OCA increases hepatic blood perfusion and uptake clearance of conjugated bile acids.OCA reduces the time hepatocytes are exposed to potentially toxic bil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
46
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 61 publications
(48 citation statements)
references
References 42 publications
0
46
0
2
Order By: Relevance
“…We appreciate the interest of Dr Javitt 1 in our recent study in patients with primary biliary cholangitis concerning the effect of obeticholic acid on the transport of the bile acid tracer [Nmethyl- 11 C]cholylsarcosine ( 11 C-CSar) from blood to bile, using positron emission tomography (PET). 2 Dr. Javitt questions the conclusion of our study that obeticholic acid enhances the secretion of endogenous conjugated bile acids. However, Dr. Javitt seems not to be familiar with the possibility of quantifying biological processes in vivo using up-to-date molecular tracer techniques based on dynamic PET.…”
Section: To the Editormentioning
confidence: 88%
“…We appreciate the interest of Dr Javitt 1 in our recent study in patients with primary biliary cholangitis concerning the effect of obeticholic acid on the transport of the bile acid tracer [Nmethyl- 11 C]cholylsarcosine ( 11 C-CSar) from blood to bile, using positron emission tomography (PET). 2 Dr. Javitt questions the conclusion of our study that obeticholic acid enhances the secretion of endogenous conjugated bile acids. However, Dr. Javitt seems not to be familiar with the possibility of quantifying biological processes in vivo using up-to-date molecular tracer techniques based on dynamic PET.…”
Section: To the Editormentioning
confidence: 88%
“…Using the conjugated bile acid tracer [N-methyl- 11 C]cholylsarcosine, Kjaergaard et al show that obeticholic acid, which is excreted into bile by BSEP, increased the hepatic transport of the tracer, and thus endogenous conjugated bile acids, from hepatocytes into the canaliculi in patients with PSC, thereby reducing the time hepatocytes are exposed to potentially cytotoxic bile acids. 96 In a separate study in patients awaiting cholecystectomy, obeticholic acid treatment, which increases the biliary cholesterol saturation index, also enriched the bile with FGF19; this possibly led to…”
Section: Recent Studies Of Osta-ostb Functionmentioning
confidence: 99%
“…The excellent studies 1 that clearly demonstrate the enhanced clearance and excretion of [N-methyl-11 C]cholylsarcosine ( 11 S-CSar) following treatment with obeticholic acid do not fulfill criteria established by Gurpide and co-workers 2,3 for tracer studies that provide quantitative information with regard to endogenous pool sizes and their kinetics. Therefore, the conclusion that obeticholic acid improves endogenous bile acid excretion may not be correct.…”
Section: To the Editormentioning
confidence: 99%